Choroidal thickness and chorioretinal atrophy in myopic choroidal neovascularization with antiâvascular endothelial growth factor therapy
Retina Aug 09, 2017
Lee JH, et al. – The factors linked to chorioretinal atrophy (CRA) progression in myopic choroidal neovascularization (CNV) was gauged in this trial, after antiÂvascular endothelial growth factor therapy. A correlation was exhibited between chorioretinal atrophy progression with a poor long–term prognosis. Relative thinning of the subfoveal choroid about the inferior choroid and subfoveal CNV location could predispose the eyes with myopic CNV to develop CRA progression after antiÂvascular endothelial growth factor therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
